Elon says problem with Left is empathy for criminals, not the victims
All times eastern Special Report with Bret Baier The Evening Edit with Elizabeth Macdonald FOX News Radio Live Channel Coverage WATCH LIVE: President Trump holds press conference with Elon Musk
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Bombing Iran's Nuclear Sites Complicates Hunt for What's Left
(Bloomberg) -- President Donald Trump's decision to order US forces to attack three key Iranian nuclear installations may have sabotaged the Islamic Republic's known atomic capabilities, but it's also created a monumental new challenge to work out what's left and where. Bezos Wedding Draws Protests, Soul-Searching Over Tourism in Venice One Architect's Quest to Save Mumbai's Heritage From Disappearing JFK AirTrain Cuts Fares 50% This Summer to Lure Riders Off Roads NYC Congestion Toll Cuts Manhattan Gridlock by 25%, RPA Reports Trump said heavily fortified sites were 'totally obliterated' late Saturday, but independent analysis has yet to verify that claim. Rather than yielding a quick win, the strikes have complicated the task of tracking uranium and ensuring Iran doesn't build a weapon, according to three people who follow the country's nuclear program. International Atomic Energy Agency monitors remain in Iran and were inspecting more than one site a day before Israel started the bombing campaign on June 13. They are still trying to assess the extent of damage, and while military action might be able to destroy Iran's declared facilities, it also provides an incentive for Iran to take its program underground. Indeed, there's just a slim possibility that the US entering the war will convince Iran to increase IAEA cooperation, said Darya Dolzikova, a senior research fellow at the Royal United Services Institute, a London-based think tank. 'The more likely scenario is that they convince Iran that cooperation and transparency don't work and that building deeper facilities and ones not declared openly is more sensible to avoid similar targeting in future,' she said. IAEA inspectors haven't been able to verify the location of the Persian Gulf country's stockpile of near-bomb-grade uranium for more than a week. Iranian officials acknowledged breaking IAEA seals and moving it to an undisclosed location. The IAEA called on a cessation of hostilities in order to address the situation. Its 35-nation board will convene on Monday in Vienna, Director General Rafael Mariano Grossi said. Trump dispatched B-2 stealth jets laden with Massive Ordnance Penetrators, known as GBU-57 bombs, to attempt to destroy Iran's underground uranium-enrichment sites in Natanz and Fordow. Satellite images taken on Sunday of Fordow and distributed by Maxar Technologies show new craters, possible collapsed tunnel entrances and holes on top of a mountain ridge. No evidence of damage to the underground enrichment halls can be seen, and IAEA inspectors reported there were no radiation releases from the site. US Air Force General Dan Caine told a news conference on Sunday that an assessment of 'final battle damage will take some time.' Before the US intervention, images showed Israeli forces alone had met with limited success four days after the bombing began. Damage to the central facility in Natanz, located 300 kilometers (186 miles) south of Tehran, was primarily limited to electricity switch yards and transformers. The US also joined in attacking the Isfahan Nuclear Technology and Research Center, located 450 kilometers south of Tehran. That was after the IAEA re-assessed the level of damage Israel had dealt to facility. Based on satellite images and communications with Iranian counterparts Isfahan appeared 'extensively damaged,' the agency wrote late on Saturday. The IAEA's central mission is to account for gram-levels of uranium around the world and to ensure it isn't used for nuclear weapons. The latest bombing now complicates tracking Iranian uranium even further, said Tariq Rauf, the former head of the IAEA's nuclear-verification policy. 'It will now be very difficult for the IAEA to establish a material balance for the nearly 9,000 kilograms of enriched uranium, especially the nearly 410 kilograms of 60% enriched uranium,' he said. Last week, inspectors had already acknowledged they'd lost track of the location of Iran's highly enriched uranium stockpile because Israel's ongoing military assaults are preventing its inspectors from doing their work. That uranium inventory — enough to make 10 nuclear warheads at a clandestine location — was seen at Isfahan by IAEA inspectors. But the material, which could fit in as few as 16 small containers, may have already been spirited off site. 'Questions remain as to where Iran may be storing its already enriched stocks,' Dozikova said. 'These will have almost certainly been moved to hardened and undisclosed locations, out of the way of potential Israeli or US strikes.' Far from being just static points on a map, Iran's ambitions to make the fuel needed for nuclear power plants and weapons are embedded in a heavily fortified infrastructure nationwide. Thousands of scientists and engineers work at dozens of sites. Even as military analysts await new satellite images before determining the success of Trump's mission, nuclear safeguards analysts have reached the conclusion that their work is about to become significantly harder. By bombing Iran's sites, Israel and the US haven't just disrupted the IAEA's accountancy of Iran's nuclear stockpile, they've also degraded the tools that monitors will be able to use, said Robert Kelley, who led inspections of Iraq and Libya as an IAEA director. That includes the forensic method used to detect the potential diversion of uranium. 'Now that sites have been bombed and all classes of materials have been scattered everywhere the IAEA will never again be able to use environmental sampling,' he said. 'Particles of every isotopic description have infinite half-lives for forensic purposes and it will be impossible to sort out their origin.' Luxury Counterfeiters Keep Outsmarting the Makers of $10,000 Handbags Is Mark Cuban the Loudmouth Billionaire that Democrats Need for 2028? Ken Griffin on Trump, Harvard and Why Novice Investors Won't Beat the Pros The US Has More Copper Than China But No Way to Refine All of It Can 'MAMUWT' Be to Musk What 'TACO' Is to Trump? ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Kidney doctor's shooting comes as questions emerge about dialysis centers
Dr. Andre Obua drove 18 hours from Miami to Terre Haute, Indiana. He pulled up to the home of a local kidney specialist and allegedly opened fire, striking the kidney doctor in the hand before being wrestled to the ground. The only thing more unexpected than the act of violence was the apparent motive. Accused in the shooting, which occurred one month after the brazen murder of the UnitedHealthcare CEO in New York City, was Obua, a highly educated medical resident with a promising career. But Obua had become fixated on one of the least-understood corners in the big business of medicine — kidney dialysis. In letters penned from prison, in phone interviews and on a website he created, Obua shared with CBS News his grievances, discussed the Luigi Mangione case in New York, and offered hints to the underpinnings of an alleged act that landed him in jail, where he is awaiting trial on attempted murder charges. He would not directly discuss the shooting and has pleaded not guilty. Prosecutors in Vigo County, Indiana, said they consider the crime abhorrent — and a source of continued pain for the physician who was shot. CBS News is not naming the victim at the request of prosecutors. Prosecutor Terry R. Modesitt said his office determined the victim "had never done anything to justify having violence brought against him." Modesitt voiced a broader concern about what he said he fears is a growing wave of disturbing vigilante violence that has no place in a civilized society. "These cases that we read about in the news or watch on TV about the news — there's no excuse for this," Modesitt said. "Go out and protest. Write your congressman… file a complaint with the attorney general's office in your state, things like that. But no, there's never any justification to go try to murder someone." Tom Mueller, the author of "How to Make a Killing: Blood, Death and Dollars in American Medicine," spent more than five years studying the dialysis industry. He says the incident conjures many of the same complex swirl of emotions that Americans expressed after the UnitedHealthcare shooting. There is a visceral disgust for violence used to make a statement, he said. And there is long-running dismay about the shortcomings of America's health care system, which may be costing lives. That includes, he said, a rise of for-profit dialysis clinics and their impact on quality of care for those confronting end-stage kidney disease. "Unless we can talk about systemic harm done by the medical profession, the insurance profession, against patients … we're not gonna get anywhere," Mueller said. Mueller may be uniquely positioned to weigh in on both the crime and the issue that may have been underlying it. For months before the shooting, he told CBS News that he and Obua had been corresponding by email about his book. In those emails, which he described to CBS News, he says Obua never gave any indication he was spiraling towards violence. Mueller only learned of the shooting later, during an interview with CBS News. "I nearly fell off my chair when I heard," Mueller said. "My sense is that [his] level of desperation just must have found an outlet in a violent act." Dialysis under scrutiny LaQuayia "LQ" Goldring, 28, has been a dialysis patient for the past ten years. Goldring lives near Louisville, Kentucky, where she spends up to four and a half hours a day hooked up to a home dialysis machine. It acts as her kidneys, taking the blood from her body, removing the waste, then cycling it back in. "Every day I wake up, I'm thanking God that my feet even hit the ground and that my eyes open and I can still breathe on my own," she said. Goldring is one of roughly 500,000 Americans dependent on dialysis to stay alive as they wait and hope for a kidney transplant, the only available remedy for those suffering from end-stage kidney disease. She receives the treatment at home, and says dialysis clinics left her with no control over her care, treating her like a "check." She, like Mueller, believes the industry has become too focused on profits. "This is emergency room care done in the mall," Mueller said. "People are not given the tailored treatment that they need." A review of federal data by CBS News found one-third of dialysis clinics failed to meet federal standards this year — nearly 2,500 of the roughly 7,600 clinics nationwide. The average score was 60 out of 100 possible points. Criticism of the industry has been disputed by the two largest for-profit companies in the dialysis industry, Fresenius and DaVita. Fresenius told CBS News in a statement that the company maintains an "unwavering focus on improving quality of life, strengthening clinical outcomes, and extending the lifespan of those we have the privilege to serve." DaVita said in a statement that its "dedicated clinicians consistently deliver high-quality, individualized care in a complex clinical and regulatory environment." A health care "duopoly" The two companies dominate the national landscape of clinics where kidney patients come to receive regular dialysis treatments — crucial to keeping them alive. Roughly 90% of patients get their treatment in the outpatient clinics. And together, the two for-profit companies own nearly 75% of all U.S. clinics — nearly 5,600 in total. The companies have become what Mueller calls "a duopoly" as the industry has consolidated over the past three decades. The share of independently owned dialysis facilities fell from 86% to 21% during that period. In over 2,500 cities around the U.S., a single company owns every clinic. That industry dominance has a cost, according to Ryan McDevitt, a Duke University economist who co-authored a study released this month looking at the toll of the scarce competition. "This is the most concentrated health care sector across the entire U.S.," McDevitt said. McDevitt argues that Medicare's limits on how much it reimburses clinics per patient have incentivized DaVita and Fresenius to focus on filling chairs to increase their profit margins. Both companies reject that characterization. Last year alone, DaVita delivered more than 29 million dialysis treatments, earning $391 in revenue per session. That includes providing home dialysis treatments, like Goldring receives through Fresenius. Together, Davita and Fresenius reported a total of $33.7 billion in revenue from all of their businesses. McDevitt said his research found that when independent clinics are acquired by DaVita or Fresenius, their transplant referrals drop by about 10%, their patient survival rates fall by 2%, hospitalizations increase by 5%, and infection rates go up by about 12%. While kidney specialists typically dictate the type of care they want for their patients, some doctors told CBS News they felt pressure from the companies running the dialysis clinics to move patients through faster. Dr. Leonard Stern, a nephrologist now at Columbia University, said even if he believed a patient needed five hours of dialysis treatment, there were times that DaVita would refuse. "We have a corporate model that provides the least amount of care for the most amount of profit for shareholders," Stern said. Stern served as medical director of an independent for-profit dialysis center until 2005, when it was sold to DaVita. After the acquisition, he said there were times the company instructed him to make more room for new patients. He said that sometimes meant more billing for DaVita, even if it resulted in unnecessary complications and return visits for his patients. Stern left the clinic in 2013. Dr. Jeffrey Gold, a kidney specialist in Royal Oak, Michigan, said the doctors feel pressure to "get the next patient in — and make sure everybody has a spot to dialyze." McDevitt described the one-size-fits-all approach as inconsistent with patient needs. "They call it bazooka dialysis, where they pump you through the station as quickly as possible," McDevitt said, comparing the turnover model to any other volume business. "They need to turn over stations multiple times a day to hit those profit numbers, to keep shareholders happy." Reports of deficiencies Most dialysis patients rely on the federal government to pay for the treatment. The costs add up to about $40 billion a year, according to the American Association of Kidney Patients. "It's actually one percent of the entire federal budget, which is a staggering statistic," McDevitt said. Despite the expenditures — about $100,000 per patient, according to McDevitt — the U.S. has among the highest death rates for patients on dialysis among developed nations. For years, health surveyors from the Center for Medicare and Medicaid Services (CMS) have conducted routine monitoring of dialysis clinics to assess their performance. Since 2013, those officials have cited U.S. dialysis centers for more than 115,000 deficiencies, including poor hand hygiene, unsanitary conditions while handling IV medications, and inadequate training. CMS assigns every facility a "Total Performance Score," evaluating them annually on measures like patient safety, infection control and hospitalization rates. If the score is below CMS standards, the clinic is hit with a financial penalty. A CBS News review of federal data found more than 40% of the clinics run by the nation's two largest dialysis providers — DaVita and Fresenius — failed to meet those same standards this year. That's nearly 1,600 clinics. In separate statements to CBS News, both companies highlighted their performance, saying the data reflects a track record of "exemplary care." Fresenius noted that more than 65% of its dialysis centers received three stars or higher on Medicare's five-star scale — a rate the company said is higher than the national average of all U.S. dialysis providers. The company also said its employees "take immense pride in providing best-in-class, high-quality care to our patients." DaVita said in a statement to CBS News that problems in clinics were "rare and isolated" and represent "exceptions and do not reflect the exemplary care we consistently provide." "We take every concern seriously, and if we make an error, we work immediately to resolve it," DaVita said in its statement. "To mischaracterize such anomalies as systemic care failures is reckless, fear-mongering, and puts patient well-being at risk." Legal settlements top $1 billion The dialysis industry has faced legal scrutiny over the past decade from patients, their surviving relatives, and from state and federal agencies. One ongoing federal case against Fresenius accuses the firm of trying to fraudulently obtain hundreds of millions of dollars of federal funds by performing unnecessary procedures — an allegation the company denies. The two companies have settled at least 25 lawsuits. And CBS News has found that since 2015, Fresenius and DaVita paid out at least $1.13 billion in legal settlements. "I have not seen any improvement in care following these settlements," McDevitt said. A spiral towards violence Frustration over the lack of reform in the industry has been simmering for years, Mueller told CBS News. Which is why Mueller said he was not unnerved as he exchanged emails with a Miami-based medical resident who had taken an interest in dialysis — and specifically, the use of a specific medication he thought could be harming patients. "The kinds of emails he sent were totally rational, very thoughtful, extremely data-driven," Mueller said, calling Andre Obua "the last person in the world I would think to commit a violent act." Over dozens of pages, the letters Obua sent to CBS News from jail describe how he grew up in a low-income household in Ann Arbor, Michigan — a background that "shaped my world views and motivates me to advocate for the less fortunate," he wrote. He says he first heard during an internal medical rotation about the use of a medication being prescribed to kidney patients to speed up the dialysis process, which he speculated could be endangering their health. It appears from his writing that this concern went from being an interest to being an obsession. At one point, he described seeking out a lawyer to file a whistleblower lawsuit, but was ultimately persuaded he could not succeed in court. CBS News sought to verify his claims, but no kidney expert interviewed believed that the medication in question harmed patients. Nevertheless, Obua unspooled mountains of his research, theories and accusations on a public website. A source familiar with the case told CBS News Obua had drawn up a list of kidney doctors to target. Near the top was the victim of his attack in Indiana. In January, for reasons Obua would not directly address in his letters and conversations with CBS News, the 29-year-old said he loaded his car with firearms and a bag of Monopoly money — which he noted was similar to the one left behind by alleged UnitedHealthcare shooter Luigi Mangione — and headed north towards Indiana. Police reports say Obua fired at a Terre Haute kidney specialist without warning, striking the doctor in the hand. The two wrestled in the tranquil suburban driveway until police arrived and placed Obua under arrest. Mueller shakes his head when thinking about the bright future Obua seemingly abandoned that winter evening. "It says we're living in extreme times," he said. "And it's a tragic, tragic event." Modesitt, the prosecutor, said he has no sympathy for the young medical resident who's now facing attempted murder charges. "If you've got a problem in any way with the system or anything else, we have attorney generals, we have secretary of states, different entities that you can file a complaint with," Modesitt said. "But it's never justified to take the law in your own hands." Obua is scheduled to go on trial in August. Full statement of DaVita: Our dedicated clinicians consistently deliver high-quality, individualized care in a complex clinical and regulatory environment. We understand that in any healthcare setting, rare and isolated incidents may occur. However, these are diligently addressed as exceptions and do not reflect the exemplary care we consistently provide. We take every concern seriously, and if we make an error, we work immediately to resolve it. To mischaracterize such anomalies as systemic care failures is reckless, fear-mongering, and puts patient well-being at risk. Full statement of Fresenius Medical Care: Providing high-quality care is our standard, and nothing gets in the way of our patients being our North Star. By any objective measure, our ability to hire qualified staff, deliver outstanding – best-in-class – patient care, and innovate for the betterment of people living with kidney disease far outpaces the industry. This is evidenced by the fact that the most recently available CMS (Centers for Medicare & Medicaid Services) 5-Star quality data, which concluded that more than 65% of all Fresenius Kidney Care (FKC) dialysis centers received 3 stars or higher – higher than the combined national average of all U.S. dialysis providers. Our approximately 70,000 employees and care teams, working across more than 2,600 dialysis centers, and delivering over 31 million treatments annually in the U.S. take immense pride in providing best-in-class, high-quality care to our patients. And our ability to introduce revolutionary advancements and innovation in kidney care, including the upcoming introduction of the 5008X™ CAREsystem in the U.S. that will deliver high-volume hemodiafiltration starting later in 2025, demonstrates our unwavering focus on improving quality of life, strengthening clinical outcomes, and extending the lifespan of those we have the privilege to serve. Netanyahu reacts to U.S. strikes on Iranian nuclear sites Some key Democratic congressional leaders left out of Trump's Iran attack plans Extended interview: LQ Goldring on her quest for a kidney donor
Newsweek
23 minutes ago
- Newsweek
Before and After Images Show Impact of US Strikes on Iran Nuclear Site
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New satellite imagery shows large craters and ash at Iran's Fordow nuclear facility following U.S. airstrikes that President Donald Trump said had "totally obliterated" Tehran's major nuclear sites. The Context Trump confirmed late on Saturday that the U.S. had carried out "massive precision strikes" to take out Tehran's nuclear enrichment facilities and damage its ability to make a nuclear weapon. Fordow nuclear site in central Iran on Friday, prior to U.S. strikes on the complex on Saturday afternoon U.S. time. Fordow nuclear site in central Iran on Friday, prior to U.S. strikes on the complex on Saturday afternoon U.S. time. Satellite image ©2025 Maxar Technologies A view of the exterior of Fordow, a major nuclear site in central Iran on Sunday, after U.S. strikes on the facility on Saturday evening U.S. time. A view of the exterior of Fordow, a major nuclear site in central Iran on Sunday, after U.S. strikes on the facility on Saturday evening U.S. time. Satellite image ©2025 Maxar Technologies What To Know The U.S. struck Fordow, roughly 60 miles south of Tehran, as well as the Natanz complex to the southeast and Isfahan, southwest of Natanz, Trump said. The president hailed the attacks as a "spectacular military success," adding: "Iran's key nuclear enrichment facilities have been completely and totally obliterated." Experts said it was too early to tell exactly how much damage has been done to Iran's network of nuclear sites. General Dan Caine, the chairman of the U.S. joint chiefs of staff, said on Sunday morning that initial assessments of the operation dubbed Midnight Hammer indicated "all three sites sustained extremely severe damage and destruction," but analysis was ongoing. Israel continued attacking Iran into Sunday, and Tehran launched fresh strikes on several Israeli cities. Satellite imagery published by space imagery firm Maxar on Sunday showed a number of large craters or holes at the top of the ridge, under which is the underground complex at Fordow. Ash from airstrikes covers much of the area, and several of the entrances to Fordow's tunnel network appear to be blocked with dirt, Maxar said. Images separately published by Planet Labs on Sunday also showed ash covering the area around Fordow. Fordow is built under a mountain, a facility that was secret until 2009 and Israel has been unable to destroy with its weapons. While Israel has carried out strikes on Iran's nuclear sites—including Natanz and Isfahan—since it started its campaign over a week ago, the U.S. is considered the only country able to reach the deeply buried sites like Fordow using B-2 bombers and "bunker buster" bombs. These huge bombs had never been used before in combat. A view of Fordow prior to U.S. airstrikes on the underground complex, taken on Thursday, June 19, 2025. A view of Fordow prior to U.S. airstrikes on the underground complex, taken on Thursday, June 19, 2025. Satellite image ©2025 Maxar Technologies Craters are visible and ash can be seen on the ridge at Fordow on Sunday, after U.S. strikes on the underground facility. Craters are visible and ash can be seen on the ridge at Fordow on Sunday, after U.S. strikes on the underground facility. Satellite image ©2025 Maxar Technologies Caine told the media on Sunday morning that the U.S. had used a total of 14 30,000-pound GBU-57/B bombs against two nuclear target areas in Iran. Reports had suggested at least one GBU-57/B was fired on Natanz. A U.S. submarine launched more than 2 dozen Tomahawk cruise missiles against the aboveground facilities at Isfahan around 5 p.m. ET on Saturday, just before U.S. aircraft entered Iranian airspace. Washington used deception tactics and a host of fourth- and fifth-generation aircraft traveling ahead of B-2 bombers to sweep for Iranian fighter jets and air defenses, Caine said. At 6:40 p.m. ET, the first B-2 dropped two "bunker buster" bombs at Fordow, the chairman said. The rest of the munitions were dropped in the following 25 minutes, and Iran did not fire any shots at U.S. aircraft traveling in or out of Iran, Caine added. Caine said full damage assessments were still pending, but that "all three sites sustained extremely severe damage and destruction." The U.S. "achieved destruction of capabilities" at Fordow, U.S. Defense Secretary Pete Hegseth said. What People Are Saying U.S. Defense Secretary Pete Hegseth, speaking alongside General Dan Caine on Sunday, said, "Iran's nuclear ambitions have been obliterated." What Happens Next Trump has threatened further strikes on Iran if Tehran does not negotiate a deal, while the country's foreign minister, Abbas Araghchi called the American attacks "outrageous," promising "everlasting consequences."
